Literature DB >> 21689701

Material properties in complement activation.

S Moein Moghimi1, Alina J Andersen, Davoud Ahmadvand, Peter P Wibroe, Thomas L Andresen, A Christy Hunter.   

Abstract

Uncontrolled complement activation can induce many inflammatory and life threatening conditions. Accordingly, the role of complement in initiation of adverse reactions to polymers and nanoparticulate drug carriers is receiving increasing attention and has prompted extensive 'structure-immune performance' relationship studies in nanomedicine research at many fronts. The interaction between nanomaterials and the complement system is complex and regulated by inter-related factors that include nanoscale size, morphology and surface characteristics. Each of these parameters may affect complement activation differently and through different sensing molecules and initiation pathways. The importance of material properties in triggering complement is considered and mechanistic aspects discussed. Mechanistic understanding of complement events could provide rational approaches for improved material design and nanoengineering strategies for clinical medicine.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21689701     DOI: 10.1016/j.addr.2011.06.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  52 in total

Review 1.  Nanoparticle mediated non-covalent drug delivery.

Authors:  Tennyson Doane; Clemens Burda
Journal:  Adv Drug Deliv Rev       Date:  2012-06-01       Impact factor: 15.470

2.  Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.

Authors:  Hanmant Gaikwad; Yue Li; Geoffrey Gifford; Ernest Groman; Nirmal K Banda; Laura Saba; Robert Scheinman; Guankui Wang; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2020-06-29       Impact factor: 4.774

3.  Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis.

Authors:  Hui-fang Zhou; Huimin Yan; Hua Pan; Kirk K Hou; Antonina Akk; Luke E Springer; Ying Hu; J Stacy Allen; Samuel A Wickline; Christine T N Pham
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

4.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

Review 5.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 6.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 7.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 8.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

9.  Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

Authors:  Seyed Moein Moghimi; Fatemeh Rahbarizadeh; Davoud Ahmadvand; Ladan Parhamifar
Journal:  Bioimpacts       Date:  2013-01-27

10.  Complement activation turnover on surfaces of nanoparticles.

Authors:  S M Moghimi; D Simberg
Journal:  Nano Today       Date:  2017-04-12       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.